338 related articles for article (PubMed ID: 26683599)
1. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
[TBL] [Abstract][Full Text] [Related]
2. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
[TBL] [Abstract][Full Text] [Related]
3. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
[TBL] [Abstract][Full Text] [Related]
4. Long-term impact of intrathoracic impedance findings on survival and heart failure hospitalizations after cardiac resynchronization therapy in ICD Registry patients.
Brown JR; Alonso A; Warman EN; Bilchick KC
Europace; 2018 Jul; 20(7):1138-1145. PubMed ID: 29016777
[TBL] [Abstract][Full Text] [Related]
5. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
[TBL] [Abstract][Full Text] [Related]
6. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study.
Piotrowicz E; Zieliński T; Bodalski R; Rywik T; Dobraszkiewicz-Wasilewska B; Sobieszczańska-Małek M; Stepnowska M; Przybylski A; Browarek A; Szumowski Ł; Piotrowski W; Piotrowicz R
Eur J Prev Cardiol; 2015 Nov; 22(11):1368-77. PubMed ID: 25261268
[TBL] [Abstract][Full Text] [Related]
7. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
[TBL] [Abstract][Full Text] [Related]
8. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
[TBL] [Abstract][Full Text] [Related]
10. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H
J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507
[TBL] [Abstract][Full Text] [Related]
11. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
El-Saed A; Voigt A; Shalaby A
Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
[TBL] [Abstract][Full Text] [Related]
13. Impact of Remote Monitoring on Long-Term Prognosis in Heart Failure Patients in a Real-World Cohort: Results From All-Comers COMMIT-HF Trial.
Kurek A; Tajstra M; Gadula-Gacek E; Buchta P; Skrzypek M; Pyka L; Wasiak M; Swietlinska M; Hawranek M; Polonski L; Gasior M; Kosiuk J
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):425-431. PubMed ID: 28176442
[TBL] [Abstract][Full Text] [Related]
14. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
[TBL] [Abstract][Full Text] [Related]
15. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
[TBL] [Abstract][Full Text] [Related]
17. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.
Gudmundsson K; Lyngå P; Rosenqvist M; Braunschweig F
Clin Cardiol; 2016 Aug; 39(8):446-52. PubMed ID: 27175605
[TBL] [Abstract][Full Text] [Related]
19. Intrathoracic impedance monitoring to predict decompensated heart failure.
Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
[TBL] [Abstract][Full Text] [Related]
20. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
